Recursion to Report Third Quarter 2024 Business Updates and Financial Results on November 6th

Company Updates - Recursion (NASDAQ: RXRX) will provide business updates and report its Q3 2024 financial results on November 6, 2024, after market close [1] - The company will not hold its usual earnings call for Q3 but plans to host an update call after the proposed business combination with Exscientia, expected on November 20, 2024 [1] Business Model and Technology - Recursion is a clinical stage TechBio company focused on decoding biology to industrialize drug discovery [1] - The company utilizes the Recursion OS, a platform that integrates diverse technologies to expand a large proprietary biological and chemical dataset [1] - Recursion employs advanced machine-learning algorithms to identify trillions of searchable relationships in biology and chemistry, minimizing human bias [1] - The company conducts millions of wet lab experiments weekly and operates one of the world's most powerful supercomputers to enhance drug discovery [1] Corporate Presence - Recursion is headquartered in Salt Lake City and is a founding member of BioHive, a collective for Utah's life sciences industry [1] - The company has additional offices in Toronto, Montréal, London, and the San Francisco Bay Area [1]